Antisense

An antisense therapy developed by Joel D. Richter, PhD, Sneha Shah, PhD, and Jonathan K. Watts, PhD, at UMass Chan Medical School and Elizabeth Berry-Kravis, MD, PhD, at RUSH University…

Multiple doses of STK-001, an investigational antisense oligonucleotide to treat Dravet syndrome, were well tolerated and showed…

Patients with hereditary angioedema who were treated with an antisense oligonucleotide treatment,…

SOUTH SAN FRANCISCO, Calif., Oct. 11, 2021 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel…